Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Pulmonary Drugs Market 2018, Forecast to 2023

January 2019 | 137 pages | ID: G638F9F536EEN
GlobalInfoResearch

Abstracts

The pulmonary drugs are used for treating the conditions affecting lungs. The pulmonary drugs are used from treating minor illnesses such as the common cold to cure long-term disorders such asthma. These agents are available in different forms such as oral tablets, oral liquids, and injections or inhalations. Inhalations deliver the medicine directly to the lungs, which can act directly on the lung tissues, minimizing systemic side effects.

Scope of the Report:

This report focuses on the Pulmonary Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The major factors driving growth of the pulmonary drugs market include increasing incidence of chronic respiratory diseases, tobacco smoking, and government and non-government initiatives.

The worldwide market for Pulmonary Drugs is expected to grow at a CAGR of roughly 8.3% over the next five years, will reach 49000 million US$ in 2023, from 30400 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• Sanofi SA
• Meda Pharmaceuticals
• Circassia Pharmaceuticals Plc.
• AstraZeneca Plc.
• GlaxoSmithKline Plc.
• Mallinckrodt Pharmaceuticals Plc.
• Cheisi Farmaceutici S.p.A
• Zambon Company S.p.A
• Alaxia SAS
• Merck Sharp & Dohme Limited

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Inhaled Corticosteroids
• Long Acting Beta-2 Agonists
• Antihistamines
• Vasodilators
• Others

Market Segment by Applications, can be divided into

• Asthma & COPD
• Allergic Rhinitis
• Pulmonary Arterial Hypertension
• Cystic Fibrosis
• Others

There are 15 Chapters to deeply display the global Pulmonary Drugs market.

Chapter 1, to describe Pulmonary Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Pulmonary Drugs, with sales, revenue, and price of Pulmonary Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Pulmonary Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Pulmonary Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Pulmonary Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Pulmonary Drugs Introduction
1.2 Market Analysis by Type
  1.2.1 Inhaled Corticosteroids
  1.2.2 Long Acting Beta-2 Agonists
  1.2.3 Antihistamines
  1.2.4 Vasodilators
  1.2.5 Others
1.3 Market Analysis by Applications
  1.3.1 Asthma & COPD
  1.3.2 Allergic Rhinitis
  1.3.3 Pulmonary Arterial Hypertension
  1.3.4 Cystic Fibrosis
  1.3.5 Others
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Sanofi SA
  2.1.1 Business Overview
    2.1.1.1 Sanofi SA Description
    2.1.1.2 Sanofi SA Headquarter, Main Business and Finance Overview
  2.1.2 Sanofi SA Pulmonary Drugs Product Introduction
    2.1.2.1 Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Pulmonary Drugs Product Information
  2.1.3 Sanofi SA Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 Sanofi SA Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global Sanofi SA Pulmonary Drugs Market Share in 2017
2.2 Meda Pharmaceuticals
  2.2.1 Business Overview
    2.2.1.1 Meda Pharmaceuticals Description
    2.2.1.2 Meda Pharmaceuticals Headquarter, Main Business and Finance Overview
  2.2.2 Meda Pharmaceuticals Pulmonary Drugs Product Introduction
    2.2.2.1 Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Pulmonary Drugs Product Information
  2.2.3 Meda Pharmaceuticals Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 Meda Pharmaceuticals Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global Meda Pharmaceuticals Pulmonary Drugs Market Share in 2017
2.3 Circassia Pharmaceuticals Plc.
  2.3.1 Business Overview
    2.3.1.1 Circassia Pharmaceuticals Plc. Description
    2.3.1.2 Circassia Pharmaceuticals Plc. Headquarter, Main Business and Finance Overview
  2.3.2 Circassia Pharmaceuticals Plc. Pulmonary Drugs Product Introduction
    2.3.2.1 Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Pulmonary Drugs Product Information
  2.3.3 Circassia Pharmaceuticals Plc. Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 Circassia Pharmaceuticals Plc. Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global Circassia Pharmaceuticals Plc. Pulmonary Drugs Market Share in 2017
2.4 AstraZeneca Plc.
  2.4.1 Business Overview
    2.4.1.1 AstraZeneca Plc. Description
    2.4.1.2 AstraZeneca Plc. Headquarter, Main Business and Finance Overview
  2.4.2 AstraZeneca Plc. Pulmonary Drugs Product Introduction
    2.4.2.1 Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Pulmonary Drugs Product Information
  2.4.3 AstraZeneca Plc. Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 AstraZeneca Plc. Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global AstraZeneca Plc. Pulmonary Drugs Market Share in 2017
2.5 GlaxoSmithKline Plc.
  2.5.1 Business Overview
    2.5.1.1 GlaxoSmithKline Plc. Description
    2.5.1.2 GlaxoSmithKline Plc. Headquarter, Main Business and Finance Overview
  2.5.2 GlaxoSmithKline Plc. Pulmonary Drugs Product Introduction
    2.5.2.1 Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Pulmonary Drugs Product Information
  2.5.3 GlaxoSmithKline Plc. Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.1 GlaxoSmithKline Plc. Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Global GlaxoSmithKline Plc. Pulmonary Drugs Market Share in 2017
2.6 Mallinckrodt Pharmaceuticals Plc.
  2.6.1 Business Overview
    2.6.1.1 Mallinckrodt Pharmaceuticals Plc. Description
    2.6.1.2 Mallinckrodt Pharmaceuticals Plc. Headquarter, Main Business and Finance Overview
  2.6.2 Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Product Introduction
    2.6.2.1 Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Pulmonary Drugs Product Information
  2.6.3 Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.1 Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Global Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Market Share in 2017
2.7 Cheisi Farmaceutici S.p.A
  2.7.1 Business Overview
    2.7.1.1 Cheisi Farmaceutici S.p.A Description
    2.7.1.2 Cheisi Farmaceutici S.p.A Headquarter, Main Business and Finance Overview
  2.7.2 Cheisi Farmaceutici S.p.A Pulmonary Drugs Product Introduction
    2.7.2.1 Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Pulmonary Drugs Product Information
  2.7.3 Cheisi Farmaceutici S.p.A Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.1 Cheisi Farmaceutici S.p.A Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Global Cheisi Farmaceutici S.p.A Pulmonary Drugs Market Share in 2017
2.8 Zambon Company S.p.A
  2.8.1 Business Overview
    2.8.1.1 Zambon Company S.p.A Description
    2.8.1.2 Zambon Company S.p.A Headquarter, Main Business and Finance Overview
  2.8.2 Zambon Company S.p.A Pulmonary Drugs Product Introduction
    2.8.2.1 Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
    2.8.2.2 Pulmonary Drugs Product Information
  2.8.3 Zambon Company S.p.A Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.1 Zambon Company S.p.A Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.2 Global Zambon Company S.p.A Pulmonary Drugs Market Share in 2017
2.9 Alaxia SAS
  2.9.1 Business Overview
    2.9.1.1 Alaxia SAS Description
    2.9.1.2 Alaxia SAS Headquarter, Main Business and Finance Overview
  2.9.2 Alaxia SAS Pulmonary Drugs Product Introduction
    2.9.2.1 Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
    2.9.2.2 Pulmonary Drugs Product Information
  2.9.3 Alaxia SAS Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.1 Alaxia SAS Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.2 Global Alaxia SAS Pulmonary Drugs Market Share in 2017
2.10 Merck Sharp & Dohme Limited
  2.10.1 Business Overview
    2.10.1.1 Merck Sharp & Dohme Limited Description
    2.10.1.2 Merck Sharp & Dohme Limited Headquarter, Main Business and Finance Overview
  2.10.2 Merck Sharp & Dohme Limited Pulmonary Drugs Product Introduction
    2.10.2.1 Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
    2.10.2.2 Pulmonary Drugs Product Information
  2.10.3 Merck Sharp & Dohme Limited Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.1 Merck Sharp & Dohme Limited Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.2 Global Merck Sharp & Dohme Limited Pulmonary Drugs Market Share in 2017

3 GLOBAL PULMONARY DRUGS MARKET COMPETITION, BY MANUFACTURER

3.1 Global Pulmonary Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Pulmonary Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Pulmonary Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Pulmonary Drugs Manufacturer Market Share in 2017
  3.4.2 Top 5 Pulmonary Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL PULMONARY DRUGS MARKET ANALYSIS BY REGIONS

4.1 Global Pulmonary Drugs Sales, Revenue and Market Share by Regions
  4.1.1 Global Pulmonary Drugs Sales by Regions (2013-2018)
  4.1.2 Global Pulmonary Drugs Revenue by Regions (2013-2018)
4.2 North America Pulmonary Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Pulmonary Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Pulmonary Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Pulmonary Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Pulmonary Drugs Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA PULMONARY DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Pulmonary Drugs Sales, Revenue and Market Share by Countries
  5.1.1 North America Pulmonary Drugs Sales by Countries (2013-2018)
  5.1.2 North America Pulmonary Drugs Revenue by Countries (2013-2018)
  5.1.3 United States Pulmonary Drugs Sales and Growth Rate (2013-2018)
  5.1.4 Canada Pulmonary Drugs Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Pulmonary Drugs Sales and Growth Rate (2013-2018)
5.2 North America Pulmonary Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Pulmonary Drugs Sales by Manufacturers (2016-2017)
  5.2.2 North America Pulmonary Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Pulmonary Drugs Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Pulmonary Drugs Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Pulmonary Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Pulmonary Drugs Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Pulmonary Drugs Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Pulmonary Drugs Revenue and Revenue Share by Application (2013-2018)

6 EUROPE PULMONARY DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Pulmonary Drugs Sales, Revenue and Market Share by Countries
  6.1.1 Europe Pulmonary Drugs Sales by Countries (2013-2018)
  6.1.2 Europe Pulmonary Drugs Revenue by Countries (2013-2018)
  6.1.3 Germany Pulmonary Drugs Sales and Growth Rate (2013-2018)
  6.1.4 UK Pulmonary Drugs Sales and Growth Rate (2013-2018)
  6.1.5 France Pulmonary Drugs Sales and Growth Rate (2013-2018)
  6.1.6 Russia Pulmonary Drugs Sales and Growth Rate (2013-2018)
  6.1.7 Italy Pulmonary Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Pulmonary Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Pulmonary Drugs Sales by Manufacturers (2016-2017)
  6.2.2 Europe Pulmonary Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Pulmonary Drugs Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Pulmonary Drugs Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Pulmonary Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Pulmonary Drugs Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Pulmonary Drugs Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Pulmonary Drugs Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC PULMONARY DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Pulmonary Drugs Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Pulmonary Drugs Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Pulmonary Drugs Revenue by Countries (2013-2018)
  7.1.3 China Pulmonary Drugs Sales and Growth Rate (2013-2018)
  7.1.4 Japan Pulmonary Drugs Sales and Growth Rate (2013-2018)
  7.1.5 Korea Pulmonary Drugs Sales and Growth Rate (2013-2018)
  7.1.6 India Pulmonary Drugs Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Pulmonary Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Pulmonary Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Pulmonary Drugs Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Pulmonary Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Pulmonary Drugs Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Pulmonary Drugs Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Pulmonary Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Pulmonary Drugs Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Pulmonary Drugs Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Pulmonary Drugs Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA PULMONARY DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Pulmonary Drugs Sales, Revenue and Market Share by Countries
  8.1.1 South America Pulmonary Drugs Sales by Countries (2013-2018)
  8.1.2 South America Pulmonary Drugs Revenue by Countries (2013-2018)
  8.1.3 Brazil Pulmonary Drugs Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Pulmonary Drugs Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Pulmonary Drugs Sales and Growth Rate (2013-2018)
8.2 South America Pulmonary Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Pulmonary Drugs Sales by Manufacturers (2016-2017)
  8.2.2 South America Pulmonary Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Pulmonary Drugs Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Pulmonary Drugs Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Pulmonary Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Pulmonary Drugs Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Pulmonary Drugs Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Pulmonary Drugs Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA PULMONARY DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Pulmonary Drugs Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Pulmonary Drugs Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Pulmonary Drugs Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Pulmonary Drugs Sales and Growth Rate (2013-2018)
  9.1.4 UAE Pulmonary Drugs Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Pulmonary Drugs Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Pulmonary Drugs Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Pulmonary Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Pulmonary Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Pulmonary Drugs Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Pulmonary Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Pulmonary Drugs Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Pulmonary Drugs Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Pulmonary Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Pulmonary Drugs Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Pulmonary Drugs Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Pulmonary Drugs Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL PULMONARY DRUGS MARKET SEGMENT BY TYPE

10.1 Global Pulmonary Drugs Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Pulmonary Drugs Sales and Market Share by Type (2013-2018)
  10.1.2 Global Pulmonary Drugs Revenue and Market Share by Type (2013-2018)
10.2 Inhaled Corticosteroids Sales Growth and Price
  10.2.1 Global Inhaled Corticosteroids Sales Growth (2013-2018)
  10.2.2 Global Inhaled Corticosteroids Price (2013-2018)
10.3 Long Acting Beta-2 Agonists Sales Growth and Price
  10.3.1 Global Long Acting Beta-2 Agonists Sales Growth (2013-2018)
  10.3.2 Global Long Acting Beta-2 Agonists Price (2013-2018)
10.4 Antihistamines Sales Growth and Price
  10.4.1 Global Antihistamines Sales Growth (2013-2018)
  10.4.2 Global Antihistamines Price (2013-2018)
10.5 Vasodilators Sales Growth and Price
  10.5.1 Global Vasodilators Sales Growth (2013-2018)
  10.5.2 Global Vasodilators Price (2013-2018)
10.6 Others Sales Growth and Price
  10.6.1 Global Others Sales Growth (2013-2018)
  10.6.2 Global Others Price (2013-2018)

11 GLOBAL PULMONARY DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Pulmonary Drugs Sales Market Share by Application (2013-2018)
11.2 Asthma & COPD Sales Growth (2013-2018)
11.3 Allergic Rhinitis Sales Growth (2013-2018)
11.4 Pulmonary Arterial Hypertension Sales Growth (2013-2018)
11.5 Cystic Fibrosis Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)

12 PULMONARY DRUGS MARKET FORECAST (2018-2023)

12.1 Global Pulmonary Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Pulmonary Drugs Market Forecast by Regions (2018-2023)
  12.2.1 North America Pulmonary Drugs Market Forecast (2018-2023)
  12.2.2 Europe Pulmonary Drugs Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Pulmonary Drugs Market Forecast (2018-2023)
  12.2.4 South America Pulmonary Drugs Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Pulmonary Drugs Market Forecast (2018-2023)
12.3 Pulmonary Drugs Market Forecast by Type (2018-2023)
  12.3.1 Global Pulmonary Drugs Sales Forecast by Type (2018-2023)
  12.3.2 Global Pulmonary Drugs Market Share Forecast by Type (2018-2023)
12.4 Pulmonary Drugs Market Forecast by Application (2018-2023)
  12.4.1 Global Pulmonary Drugs Sales Forecast by Application (2018-2023)
  12.4.2 Global Pulmonary Drugs Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data

List Of Tables

LIST OF TABLES AND FIGURES

Figure Pulmonary Drugs Picture
Table Product Specifications of Pulmonary Drugs
Figure Global Pulmonary Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Pulmonary Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Pulmonary Drugs by Types in 2017
Figure Inhaled Corticosteroids Picture
Table Major Manufacturers of Inhaled Corticosteroids
Figure Long Acting Beta-2 Agonists Picture
Table Major Manufacturers of Long Acting Beta-2 Agonists
Figure Antihistamines Picture
Table Major Manufacturers of Antihistamines
Figure Vasodilators Picture
Table Major Manufacturers of Vasodilators
Figure Others Picture
Table Major Manufacturers of Others
Figure Pulmonary Drugs Sales Market Share by Applications in 2017
Figure Asthma & COPD Picture
Figure Allergic Rhinitis Picture
Figure Pulmonary Arterial Hypertension Picture
Figure Cystic Fibrosis Picture
Figure Others Picture
Figure United States Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Pulmonary Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Sanofi SA Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi SA Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
Table Sanofi SA Pulmonary Drugs Product
Table Sanofi SA Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi SA Pulmonary Drugs Sales Market Share in 2017
Figure Global Sanofi SA Pulmonary Drugs Revenue Market Share in 2017
Table Meda Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Meda Pharmaceuticals Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
Table Meda Pharmaceuticals Pulmonary Drugs Product
Table Meda Pharmaceuticals Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Meda Pharmaceuticals Pulmonary Drugs Sales Market Share in 2017
Figure Global Meda Pharmaceuticals Pulmonary Drugs Revenue Market Share in 2017
Table Circassia Pharmaceuticals Plc. Headquarter, Established, Main Business and Finance Overview (2017)
Table Circassia Pharmaceuticals Plc. Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
Table Circassia Pharmaceuticals Plc. Pulmonary Drugs Product
Table Circassia Pharmaceuticals Plc. Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Circassia Pharmaceuticals Plc. Pulmonary Drugs Sales Market Share in 2017
Figure Global Circassia Pharmaceuticals Plc. Pulmonary Drugs Revenue Market Share in 2017
Table AstraZeneca Plc. Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca Plc. Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
Table AstraZeneca Plc. Pulmonary Drugs Product
Table AstraZeneca Plc. Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca Plc. Pulmonary Drugs Sales Market Share in 2017
Figure Global AstraZeneca Plc. Pulmonary Drugs Revenue Market Share in 2017
Table GlaxoSmithKline Plc. Headquarter, Established, Main Business and Finance Overview (2017)
Table GlaxoSmithKline Plc. Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
Table GlaxoSmithKline Plc. Pulmonary Drugs Product
Table GlaxoSmithKline Plc. Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GlaxoSmithKline Plc. Pulmonary Drugs Sales Market Share in 2017
Figure Global GlaxoSmithKline Plc. Pulmonary Drugs Revenue Market Share in 2017
Table Mallinckrodt Pharmaceuticals Plc. Headquarter, Established, Main Business and Finance Overview (2017)
Table Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
Table Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Product
Table Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Sales Market Share in 2017
Figure Global Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Revenue Market Share in 2017
Table Cheisi Farmaceutici S.p.A Headquarter, Established, Main Business and Finance Overview (2017)
Table Cheisi Farmaceutici S.p.A Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
Table Cheisi Farmaceutici S.p.A Pulmonary Drugs Product
Table Cheisi Farmaceutici S.p.A Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Cheisi Farmaceutici S.p.A Pulmonary Drugs Sales Market Share in 2017
Figure Global Cheisi Farmaceutici S.p.A Pulmonary Drugs Revenue Market Share in 2017
Table Zambon Company S.p.A Headquarter, Established, Main Business and Finance Overview (2017)
Table Zambon Company S.p.A Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
Table Zambon Company S.p.A Pulmonary Drugs Product
Table Zambon Company S.p.A Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Zambon Company S.p.A Pulmonary Drugs Sales Market Share in 2017
Figure Global Zambon Company S.p.A Pulmonary Drugs Revenue Market Share in 2017
Table Alaxia SAS Headquarter, Established, Main Business and Finance Overview (2017)
Table Alaxia SAS Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
Table Alaxia SAS Pulmonary Drugs Product
Table Alaxia SAS Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Alaxia SAS Pulmonary Drugs Sales Market Share in 2017
Figure Global Alaxia SAS Pulmonary Drugs Revenue Market Share in 2017
Table Merck Sharp & Dohme Limited Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Sharp & Dohme Limited Pulmonary Drugs Production Bases, Sales Regions and Major Competitors
Table Merck Sharp & Dohme Limited Pulmonary Drugs Product
Table Merck Sharp & Dohme Limited Pulmonary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Sharp & Dohme Limited Pulmonary Drugs Sales Market Share in 2017
Figure Global Merck Sharp & Dohme Limited Pulmonary Drugs Revenue Market Share in 2017
Table Global Pulmonary Drugs Sales by Manufacturer (2016-2017)
Figure Global Pulmonary Drugs Sales Market Share by Manufacturer in 2016
Figure Global Pulmonary Drugs Sales Market Share by Manufacturer in 2017
Table Global Pulmonary Drugs Revenue by Manufacturer (2016-2017)
Figure Global Pulmonary Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Pulmonary Drugs Revenue Market Share by Manufacturer in 2017
Table Global Pulmonary Drugs Price by Manufacturer (2016-2017)
Figure Top 3 Pulmonary Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Pulmonary Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure Global Pulmonary Drugs Revenue and Growth Rate (2013-2018)
Table Global Pulmonary Drugs Sales by Regions (2013-2018)
Table Global Pulmonary Drugs Sales Market Share by Regions (2013-2018)
Table Global Pulmonary Drugs Revenue by Regions (2013-2018)
Figure Global Pulmonary Drugs Revenue Market Share by Regions in 2013
Figure Global Pulmonary Drugs Revenue Market Share by Regions in 2017
Figure North America Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure North America Pulmonary Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure Europe Pulmonary Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Pulmonary Drugs Revenue and Growth Rate (2013-2018)
Figure South America Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure South America Pulmonary Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Pulmonary Drugs Revenue and Growth Rate (2013-2018)
Figure North America Pulmonary Drugs Revenue and Growth Rate (2013-2018)
Table North America Pulmonary Drugs Sales by Countries (2013-2018)
Table North America Pulmonary Drugs Sales Market Share by Countries (2013-2018)
Figure North America Pulmonary Drugs Sales Market Share by Countries in 2013
Figure North America Pulmonary Drugs Sales Market Share by Countries in 2017
Table North America Pulmonary Drugs Revenue by Countries (2013-2018)
Table North America Pulmonary Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Pulmonary Drugs Revenue Market Share by Countries in 2013
Figure North America Pulmonary Drugs Revenue Market Share by Countries in 2017
Figure United States Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure Canada Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Pulmonary Drugs Sales and Growth Rate (2013-2018)
Table North America Pulmonary Drugs Sales by Manufacturer (2016-2017)
Figure North America Pulmonary Drugs Sales Market Share by Manufacturer in 2016
Figure North America Pulmonary Drugs Sales Market Share by Manufacturer in 2017
Table North America Pulmonary Drugs Revenue by Manufacturer (2016-2017)
Figure North America Pulmonary Drugs Revenue Market Share by Manufacturer in 2016
Figure North America Pulmonary Drugs Revenue Market Share by Manufacturer in 2017
Table North America Pulmonary Drugs Sales by Type (2013-2018)
Table North America Pulmonary Drugs Sales Share by Type (2013-2018)
Table North America Pulmonary Drugs Revenue by Type (2013-2018)
Table North America Pulmonary Drugs Revenue Share by Type (2013-2018)
Table North America Pulmonary Drugs Sales by Application (2013-2018)
Table North America Pulmonary Drugs Sales Share by Application (2013-2018)
Table North America Pulmonary Drugs Revenue by Application (2013-2018)
Table North America Pulmonary Drugs Revenue Share by Application (2013-2018)
Figure Europe Pulmonary Drugs Revenue and Growth Rate (2013-2018)
Table Europe Pulmonary Drugs Sales by Countries (2013-2018)
Table Europe Pulmonary Drugs Sales Market Share by Countries (2013-2018)
Table Europe Pulmonary Drugs Revenue by Countries (2013-2018)
Figure Europe Pulmonary Drugs Revenue Market Share by Countries in 2016
Figure Europe Pulmonary Drugs Revenue Market Share by Countries in 2017
Figure Germany Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure UK Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure France Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure Russia Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure Italy Pulmonary Drugs Sales and Growth Rate (2013-2018)
Table Europe Pulmonary Drugs Sales by Manufacturer (2016-2017)
Figure Europe Pulmonary Drugs Sales Market Share by Manufacturer in 2016
Figure Europe Pulmonary Drugs Sales Market Share by Manufacturer in 2017
Table Europe Pulmonary Drugs Revenue by Manufacturer (2016-2017)
Figure Europe Pulmonary Drugs Revenue Market Share by Manufacturer in 2016
Figure Europe Pulmonary Drugs Revenue Market Share by Manufacturer in 2017
Table Europe Pulmonary Drugs Sales by Type (2013-2018)
Table Europe Pulmonary Drugs Sales Share by Type (2013-2018)
Table Europe Pulmonary Drugs Revenue by Type (2013-2018)
Table Europe Pulmonary Drugs Revenue Share by Type (2013-2018)
Table Europe Pulmonary Drugs Sales by Application (2013-2018)
Table Europe Pulmonary Drugs Sales Share by Application (2013-2018)
Table Europe Pulmonary Drugs Revenue by Application (2013-2018)
Table Europe Pulmonary Drugs Revenue Share by Application (2013-2018)
Figure Asia-Pacific Pulmonary Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Pulmonary Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Pulmonary Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Pulmonary Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Pulmonary Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Pulmonary Drugs Revenue Market Share by Countries 2017
Figure China Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure Japan Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure Korea Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure India Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Pulmonary Drugs Sales and Growth Rate (2013-2018)
Table Asia-Pacific Pulmonary Drugs Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Pulmonary Drugs Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Pulmonary Drugs Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Pulmonary Drugs Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Pulmonary Drugs Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Pulmonary Drugs Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Pulmonary Drugs Sales by Type (2013-2018)
Table Asia-Pacific Pulmonary Drugs Sales Share by Type (2013-2018)
Table Asia-Pacific Pulmonary Drugs Revenue by Type (2013-2018)
Table Asia-Pacific Pulmonary Drugs Revenue Share by Type (2013-2018)
Table Asia-Pacific Pulmonary Drugs Sales by Application (2013-2018)
Table Asia-Pacific Pulmonary Drugs Sales Share by Application (2013-2018)
Table Asia-Pacific Pulmonary Drugs Revenue by Application (2013-2018)
Table Asia-Pacific Pulmonary Drugs Revenue Share by Application (2013-2018)
Figure South America Pulmonary Drugs Revenue and Growth Rate (2013-2018)
Table South America Pulmonary Drugs Sales by Countries (2013-2018)
Table South America Pulmonary Drugs Sales Market Share by Countries (2013-2018)
Figure South America Pulmonary Drugs Sales Market Share by Countries in 2017
Table South America Pulmonary Drugs Revenue by Countries (2013-2018)
Table South America Pulmonary Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Pulmonary Drugs Revenue Market Share by Countries in 2017
Figure Brazil Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Pulmonary Drugs Sales and Growth Rate (2013-2018)
Table South America Pulmonary Drugs Sales by Manufacturer (2016-2017)
Figure South America Pulmonary Drugs Sales Market Share by Manufacturer in 2016
Figure South America Pulmonary Drugs Sales Market Share by Manufacturer in 2017
Table South America Pulmonary Drugs Revenue by Manufacturer (2016-2017)
Figure South America Pulmonary Drugs Revenue Market Share by Manufacturer in 2016
Figure South America Pulmonary Drugs Revenue Market Share by Manufacturer in 2017
Table South America Pulmonary Drugs Sales by Type (2013-2018)
Table South America Pulmonary Drugs Sales Share by Type (2013-2018)
Table South America Pulmonary Drugs Revenue by Type (2013-2018)
Table South America Pulmonary Drugs Revenue Share by Type (2013-2018)
Table South America Pulmonary Drugs Sales by Application (2013-2018)
Table South America Pulmonary Drugs Sales Share by Application (2013-2018)
Table South America Pulmonary Drugs Revenue by Application (2013-2018)
Table South America Pulmonary Drugs Revenue Share by Application (2013-2018)
Figure Middle East and Africa Pulmonary Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Pulmonary Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Pulmonary Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Pulmonary Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Pulmonary Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Pulmonary Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Pulmonary Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Pulmonary Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure UAE Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Pulmonary Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Pulmonary Drugs Sales and Growth Rate (2013-2018)
Table Middle East and Africa Pulmonary Drugs Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Pulmonary Drugs Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Pulmonary Drugs Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Pulmonary Drugs Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Pulmonary Drugs Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Pulmonary Drugs Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Pulmonary Drugs Sales by Type (2013-2018)
Table Middle East and Africa Pulmonary Drugs Sales Share by Type (2013-2018)
Table Middle East and Africa Pulmonary Drugs Revenue by Type (2013-2018)
Table Middle East and Africa Pulmonary Drugs Revenue Share by Type (2013-2018)
Table Middle East and Africa Pulmonary Drugs Sales by Application (2013-2018)
Table Middle East and Africa Pulmonary Drugs Sales Share by Application (2013-2018)
Table Middle East and Africa Pulmonary Drugs Revenue by Application (2013-2018)
Table Middle East and Africa Pulmonary Drugs Revenue Share by Application (2013-2018)
Table Global Pulmonary Drugs Sales by Type (2013-2018)
Table Global Pulmonary Drugs Sales Share by Type (2013-2018)
Table Global Pulmonary Drugs Revenue by Type (2013-2018)
Table Global Pulmonary Drugs Revenue Share by Type (2013-2018)
Figure Global Inhaled Corticosteroids Sales Growth (2013-2018)
Figure Global Inhaled Corticosteroids Price (2013-2018)
Figure Global Long Acting Beta-2 Agonists Sales Growth (2013-2018)
Figure Global Long Acting Beta-2 Agonists Price (2013-2018)
Figure Global Antihistamines Sales Growth (2013-2018)
Figure Global Antihistamines Price (2013-2018)
Figure Global Vasodilators Sales Growth (2013-2018)
Figure Global Vasodilators Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Pulmonary Drugs Sales by Application (2013-2018)
Table Global Pulmonary Drugs Sales Share by Application (2013-2018)
Figure Global Asthma & COPD Sales Growth (2013-2018)
Figure Global Allergic Rhinitis Sales Growth (2013-2018)
Figure Global Pulmonary Arterial Hypertension Sales Growth (2013-2018)
Figure Global Cystic Fibrosis Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Pulmonary Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Pulmonary Drugs Sales Forecast by Regions (2018-2023)
Table Global Pulmonary Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Pulmonary Drugs Market Forecast (2018-2023)
Figure Europe Sales Pulmonary Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Pulmonary Drugs Market Forecast (2018-2023)
Figure South America Sales Pulmonary Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Pulmonary Drugs Market Forecast (2018-2023)
Table Global Pulmonary Drugs Sales Forecast by Type (2018-2023)
Table Global Pulmonary Drugs Market Share Forecast by Type (2018-2023)
Table Global Pulmonary Drugs Sales Forecast by Application (2018-2023)
Table Global Pulmonary Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List